放射性核素心肌灌注显像在慢性肾病患者中的应用

中华核医学与分子影像杂志 Pub Date : 2020-02-25 DOI:10.3760/CMA.J.ISSN.2095-2848.2020.02.011

Momo Sun

{"title":"放射性核素心肌灌注显像在慢性肾病患者中的应用","authors":"Momo Sun","doi":"10.3760/CMA.J.ISSN.2095-2848.2020.02.011","DOIUrl":null,"url":null,"abstract":"Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) or even those after renal transplantation. Radionuclide myocardial perfusion imaging (MPI) is an available way to predict cardiac events and make risk stratification for CKD patients with cardiovascular diseases. Early detection and individualized treatment of patients with high-risk of cardiac events by MPI can prevent myocardial infarction and heart failure, thus improving the survival rate of this population. This article reviews the application of MPI in patients with CKD. \n \n \nKey words: \nNephrosis; Chronic disease; Myocardial perfusion imaging; Trends","PeriodicalId":10099,"journal":{"name":"中华核医学与分子影像杂志","volume":"40 1","pages":"108-112"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Application of radionuclide myocardial perfusion imaging in patients with chronic kidney disease\",\"authors\":\"Momo Sun\",\"doi\":\"10.3760/CMA.J.ISSN.2095-2848.2020.02.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) or even those after renal transplantation. Radionuclide myocardial perfusion imaging (MPI) is an available way to predict cardiac events and make risk stratification for CKD patients with cardiovascular diseases. Early detection and individualized treatment of patients with high-risk of cardiac events by MPI can prevent myocardial infarction and heart failure, thus improving the survival rate of this population. This article reviews the application of MPI in patients with CKD. \\n \\n \\nKey words: \\nNephrosis; Chronic disease; Myocardial perfusion imaging; Trends\",\"PeriodicalId\":10099,\"journal\":{\"name\":\"中华核医学与分子影像杂志\",\"volume\":\"40 1\",\"pages\":\"108-112\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华核医学与分子影像杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2020.02.011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华核医学与分子影像杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.2095-2848.2020.02.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

心血管疾病是慢性肾脏疾病(CKD)患者甚至肾移植术后患者死亡的主要原因。放射性核素心肌灌注成像(MPI)是CKD合并心血管疾病患者预测心脏事件和进行风险分层的有效方法。通过MPI对心脏事件高危患者进行早期发现和个体化治疗，可以预防心肌梗死和心力衰竭，从而提高该人群的生存率。本文就MPI在CKD患者中的应用进行综述。关键词:肾病;慢性疾病;心肌灌注显像;趋势

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Application of radionuclide myocardial perfusion imaging in patients with chronic kidney disease

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) or even those after renal transplantation. Radionuclide myocardial perfusion imaging (MPI) is an available way to predict cardiac events and make risk stratification for CKD patients with cardiovascular diseases. Early detection and individualized treatment of patients with high-risk of cardiac events by MPI can prevent myocardial infarction and heart failure, thus improving the survival rate of this population. This article reviews the application of MPI in patients with CKD. Key words: Nephrosis; Chronic disease; Myocardial perfusion imaging; Trends

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

中华核医学与分子影像杂志核医学，分子影像

自引率

0.00%

发文量

5088

期刊介绍： Chinese Journal of Nuclear Medicine and Molecular Imaging (CJNMMI) was established in 1981, with the name of Chinese Journal of Nuclear Medicine, and renamed in 2012. As the specialized periodical in the domain of nuclear medicine in China, the aim of Chinese Journal of Nuclear Medicine and Molecular Imaging is to develop nuclear medicine sciences, push forward nuclear medicine education and basic construction, foster qualified personnel training and academic exchanges, and popularize related knowledge and raising public awareness. Topics of interest for Chinese Journal of Nuclear Medicine and Molecular Imaging include: -Research and commentary on nuclear medicine and molecular imaging with significant implications for disease diagnosis and treatment -Investigative studies of heart, brain imaging and tumor positioning -Perspectives and reviews on research topics that discuss the implications of findings from the basic science and clinical practice of nuclear medicine and molecular imaging - Nuclear medicine education and personnel training - Topics of interest for nuclear medicine and molecular imaging include subject coverage diseases such as cardiovascular diseases, cancer, Alzheimer’s disease, and Parkinson’s disease, and also radionuclide therapy, radiomics, molecular probes and related translational research.